LloydsPharmacy has told staff it will soon begin on a restructuring process that could result in redundancy for some employees.
In a letter sent out to LloydsPharmacy staff yesterday, McKesson UK CEO, Toby Anderson outlined potential plans to restructure the business, required to protect the company’s long-term future after facing ‘increased costs’ and a ‘reduction in income,’ which have only been exaggerated by Covid-19 pressures.
The company warned staff that the changes may result in a number of redundancies. ‘This is likely to be an unsettling time for many colleagues, but we are committed to supporting you all throughout,’ Mr Anderson said.
‘As colleagues we can all support each other by being respectful and empathetic to those who are impacted’, the CEO commented.
The formal consultation process on a number of the proposed changes will begin on 20 July.
This step comes after the business has sold over 200 stores across the UK since 2017, frozen the recruitment of non-critical roles, restricted travel, and paused pay increases for staff.
As part of the restructure, the company plans to standardise employee terms and conditions across the business in a bid to be ‘fairer and more consistent’.
‘We are evolving our culture to help make sure McKesson is a better place to work for all of our colleagues’, the CEO said.
Staff who are currently on furlough will soon hear from the company on what the restructuring process could mean for them, he explained. Employee representatives for each area of the company will be appointed.
Despite the changes, the company plans to keep investing in the business. ‘We are rolling out new technology through our ERP programme and launching a new retail dispensing system,’ Mr Anderson said.
Last week, LloydsPharmacy and online delivery company, Deliveroo, partnered up to launch a new service that offers delivery of over the counter medicines to patients’ doors in under half an hour.